SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹-2,731 Cr | ₹-1,998 Cr | ₹-1,316 Cr | ₹-1,515 Cr | ₹246 Cr |
What is the latest Total Non-Current Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹-2,731 Cr |
Mar2023 | ₹-1,998 Cr |
Mar2022 | ₹-1,316 Cr |
Mar2021 | ₹-1,515 Cr |
Mar2020 | ₹246 Cr |
How is Total Non-Current Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-2,731 Cr | Negative | |
Mar2023 | ₹-1,998 Cr | Negative | |
Mar2022 | ₹-1,316 Cr | Negative | |
Mar2021 | ₹-1,515 Cr | Negative | |
Mar2020 | ₹246 Cr | - |
Compare Total Non-Current Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹419,757.5 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,010.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹118,905.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
MANKIND PHARMA | ₹103,904.0 Cr | -2.5% | -8% | 16.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,523.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,015.0 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | 0.6% |
-2.1% |
16.5% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses